FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Delayed Deutsche Boerse AG 20:03:38 28/06/2024 BST | ||
| 2.93 EUR | -1.35% |
|
| Current month | -10.27% | ||
| 1 month | -4.19% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 2.93 | -1.35% |
| 27/06/24 | 2.97 | +12.08% |
| 26/06/24 | 2.65 | -3.28% |
| 25/06/24 | 2.74 | -1.44% |
| 24/06/24 | 2.78 | -5.44% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 08:03 pm
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SB0XTH |
| ISIN | DE000SB0XTH3 |
| Date issued | 08/06/2020 |
| Strike | 60.88 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.87 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 15.1 € |
|---|---|
| Lowest since issue | 0.27 € |
| Spread | 0.01 € |
| Spread % | 0.35% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.51
USD
Average target price
53.19
USD
Spread / Average Target
+28.15%
- Stock Market
- Certificates
- Certificat
